GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Cash Profit Margin History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Cash Profit Margin (%) | 8.24 | 10.97 |
What is the latest Cash Profit Margin ratio of GUFIC BIOSCIENCES ?
| Year | Cash Profit Margin |
|---|---|
| Mar2025 | 8.24 |
| Mar2024 | 10.97 |
How is Cash Profit Margin of GUFIC BIOSCIENCES Trending?
| Years | Cash Profit Margin | % Change | |
|---|---|---|---|
| Mar2025 | 8.24 | -24.89 | |
| Mar2024 | 10.97 | - | |
Other Financial Ratios of GUFIC BIOSCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Profit Margin ratio of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹2,885.1 Cr | -0.3% | 2.9% | -18.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,830.0 Cr | 4.7% | -0.3% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,484.0 Cr | 2.3% | 6.8% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,166.0 Cr | 2.5% | -1.7% | 26.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,018.0 Cr | 11.3% | 7.6% | 12.5% | Stock Analytics | |
| CIPLA | ₹106,357.0 Cr | 5.9% | 7.3% | -14.1% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -0.3% |
2.9% |
-18.8% |
| SENSEX | -1.3% |
4.6% |
-3.3% |
You may also like the below Video Courses